Browse studies

Find your next paid study

27,270 recruiting studies available now

Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Progressive Idiopathic Pulmonary Fibrosis (STRIVE II)

This Phase IIb trial will compare effectiveness and safety of a multi-component autoantibody reduction therapy (AART), consisting of therapeutic plasma exchang…

Idiopathic Pulmonary Fibrosis

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of Alabama at BirminghamNCT07674745

Phase 1

A Phase 1/2 Study of the Menin Inhibitor Revumenib With the CELMod Mezigdomide in Relapsed/Refractory KMT2A-rearanged, NPM1-mutant, and NUP98-rearranged Acute Leukemias

The purpose of this study is to find out whether the combination of mezigdomide and revumenib is a safe treatment for people with relapsed or refractory KMT2A-…

LeukemiaAcute LeukemiaRelapse Leukemia+5 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07356154

Phase 2

A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) i…

Crohn's DiseaseUlcerative Colitis

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT07697456

Phase 1

A Phase I Trial of Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

Background: T-cell lymphoma is a blood cancer that affects immune system cells. People tend to survive less than 1 year if this disease does not respond to tr…

Lymphoma, T Cell, PeripheralT-cell LymphomaAngioimmunoblastic T-cell Lymphoma+3 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07388563

Phase 1

A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biolo…

Locally Advanced / Metastatic Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Crescent Biopharma, Inc.NCT07335497

Phase 2Remote eligible

An Internet of Things Automated Cognitive Behavioral Therapy for Insomnia That Improves Cognition in Older Adults

This double blind randomized clinical trial on older independent-living healthy individuals with symptoms of insomnia will harness Cognitive Behavioral Therapy…

InsomniaInsomnia Chronic

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Proactive Life IncNCT07316153

Phase 3

A Multicenter Randomized Controlled Trial of Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis (ITN077AI)

This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hemat…

Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis

Estimated

~$50 – $1,350

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT04047628

Phase 3

A Phase 3, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat.

A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal …

Subcutaneous Fat

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Caliway Biopharmaceuticals Co., Ltd.NCT07526974

Phase 4

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Dupilumab on Airway Inflammation Through Assessments of Mucus Plugging and Other Lung Imaging Parameters in Patients With Chronic Obstructive Pulmonary Disease.

LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is …

Chronic Obstructive Pulmonary Disease

Estimated

~$25 – $1,500

Actual pay is set by the research site.

SanofiNCT07053423

Observational

A Randomized, Double-blind, Placebo-controlled Study Evaluating the Impact of Daily Supplementation With IgG Binding Protein LT in Support of a Healthy Gut on the Go

PS52 is a randomized, double-blind, placebo-controlled, fully decentralized study sponsored by Bactolife A/S and conducted by People Science, Inc. It evaluates…

Gut HealthGastrointestinal SymptomsSafety in Healthy Adults

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Bactolife A/SNCT07873957

Phase 2

Assessing the Feasibility of Daily Low Dose Tadalafil and Subsequent Effects on Cognition and Cerebral Vasomotor Reactivity in Elderly Patients With Mild Cognitive Impairment

The goal of this clinical trial is to determine if taking four weeks of a daily low dose of tadalafil is possible and safe in elderly males and females with mi…

Mild Cognitive Impairment (MCI)

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Los Angeles Brain Science ProjectNCT07882901

Observational

Expanding Access to Colorectal Cancer Screening Through Community Pharmacies: The PharmFIT Study

This study will conduct a randomized controlled trial to assess the impact of a pharmacy-based FIT intervention, Pharmacy-based FIT (PharmFIT), on colorectal c…

Colorectal Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT06656936